Results 171 to 180 of about 2,202,413 (261)

Use of fibres and surface treatment to improve the durability of concrete affected by sulphide mining. [PDF]

Sci Rep
Davila JM, Rodriguez-Gomez C, Rodriguez-Gomez C, Sarmiento AM.   +3 more
europepmc   +1 more source

Added Prognostic Value of EEG Reactivity in Comatose Patients Following Cardiac Arrest

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To evaluate the added prognostic value of EEG reactivity for favorable outcome compared with background analysis during and after targeted temperature management (TTM). Methods Prospective observational cohort study of comatose post–cardiac arrest patients admitted to a single academic center between 2017 and 2022, all undergoing ...
Sarah Caroyer, Marie Obrecht, Charlotte de Maeseneire, Charlotte Damien, Chantal Depondt, Lorenzo Ferlini, Estelle Rikir, Filippo Annoni, Fabio Silvio Taccone, Nicolas Mavroudakis, Benjamin Legros, Nicolas Gaspard   +11 more
wiley   +1 more source

eSolubilized amniotic membrane ECM as a promising biological surface treatment approach for 3D-printed bone tissue engineering scaffolds. [PDF]

Sci Rep
Shorouei S, Bardeei LK, Kehtari M, Vaziri N, Taheriazam A, Moradikhah F, Jafari AM, Seyedjafari E, Salber J.   +8 more
europepmc   +1 more source

Surface Modification and Surface Treatment

Bulletin of the Japan Institute of Metals, 1984
openaire   +2 more sources

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Effect of enamel surface treatment via Er, Cr: YSGG laser and nano-hydroxyapatite toothpaste on mineral content of primary teeth via x-ray diffractometer: an in-vitro study. [PDF]

BDJ Open
Elhussini FM, Hamdy D, Abodouh AH, Allam GG.   +3 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

The effect of different surface treatment on shear bond strength of soft and hard liners to CAD-CAM and conventional denture base resins: <i>in vitro</i> comparative study. [PDF]

Front Dent Med
Albazroun Z, Aldobais FA, Aldehaileb S, Alabdullatif A, Almahdi S, Alsayoud AM, Al-Qarni FD, Alshareef A, Akhtar S, Gad MM.   +9 more
europepmc   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw, Karishma Randhave, Ekta Anand, Ziang (Debbie) Song, Wangzhen Shen, Jing‐Qiong Kang   +5 more
wiley   +1 more source

Room-Temperature Methanol Gas Sensor Based on PEDOT:Tosylate Thin Films: Enhanced Sensitivity through Urea Surface Treatment. [PDF]

ACS Omega
Ur Rehman M, Rahman MA, Dhanabalan SS, Switalska E, Komljenovic R, Tawfik SA, Gupta S, Sriram S, Evans D, Bhaskaran M.   +9 more
europepmc   +1 more source